S66 Shares Star Combo Pharma Limited
BUY ASX · ASXHealth and wellness product growth offers speculative upside from expanding distribution.
Future value: $0.27 (+92.86%) · 6-12 months
Signal breakdown
- ▸Wellness demand and distribution growth provide speculative catalyst.
- ▸Above 50-day MA (+1.23%)
- ▸~93% upside to price target
Is S66 a buy right now?
Trend: S66 is trading above the 50-day average (+0.00%), RSI 38 — neutral momentum, with a 3-month return of +7.69%.
Valuation & quality: Star Combo Pharma Limited trades on price-to-book 0.49; fundamentals show net margin 1.7%, return on equity 1.0%, revenue growth -3.5% year on year.
Income: trailing dividend yield 2.11%.
Our screen: BUY (score 2) — Health and wellness product growth offers speculative upside from expanding distribution.
Computed from end-of-day data; not personal advice.
Our track record with S66
First flagged in our daily picks as BUY on 2026-10-27 at $0.14.
Paper trades from our simulated funds at real end-of-day prices; past results don't predict future returns.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +5.60% | +15.80% | -18.20% | -22.20% | -7.10% | +7.70% | -7.10% | +7.70% |
Fundamentals
Technical signals
About Star Combo Pharma Limited
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail.
Sector: Consumer Defensive · Industry: Household & Personal Products · Australia · Website
Related Consumer Staples picks
Browse: all ASX stocks · Consumer Staples picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.